| NDC Code: |
25021-209 |
| Proprietary Name: |
Gemcitabine |
| Suffix: |
|
| Non-Proprietary Name: |
gemcitabine hydrochloride |
| Dosage Form: |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Method: |
INTRAVENOUS |
| Original Marketing Date: |
25-07-2011 |
| Category Name: |
ANDA |
| Application Number: |
ANDA079160 |
| Labeler: |
SAGENT PHARMACEUTICALS |
| Substance Name: |
GEMCITABINE HYDROCHLORIDE |
| Active Numerator Strength: |
1 |
| Active Ingredient Unit: |
g/25mL |
| Pharm Classes: |
Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| DEA Schedule: |
|
